Company intelligence / Profile preview

MC3

Wayne, PA, United Statesmc3.edu ↗

Ownership: Private
Development stage: Other

Overview

MC3 is a leading provider of custom live and virtual events, training experiences, and commercialization support for pharmaceutical and biotech companies. It merged with Curtis Learning in 2022 to form a larger life sciences commercialization platform backed by Renovus Capital Partners. The combined entity supports product launches and ongoing education across all phases of the product lifecycle for major pharma clients.

Industry: Consulting

Partnerships

Major pharmaceutical companies as clients; specific partnerships undisclosed.

Beyond the preview

Go deeper on MC3.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MC3.

Explore the full profile